#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

What happens when you compare #ShockwaveIVL# head-to-head with atherectomy in the real world? The results speak for themselves. With 1,005 patients, the ROLLING-STONE Registry is the largest prospective, multicenter study to include a head-to-head comparison of #ShockwaveIVL# and atherectomy in a real-world, all-comers population. The study confirmed strong procedural success and intraprocedural safety with Shockwave IVL. It also demonstrated a favorable 30-day MACE rate and a significantly lower 1-year MACE after propensity score matching compared with atherectomy. Read the full summary:  US Rx only. Safety Info:  Product availability may vary by country.

Safety is in our DNA and MOA. #ShockwaveIVL# delivers shockwaves that crack hard calcium without damaging soft tissue — the product of nearly a decade spent refining extracorporeal lithotripsy principles into a purpose-built vascular solution. The combination of Shockwave's acoustic waveform and energy delivery is what makes Shockwave IVL predictable safe and consistently effective. Learn more about our proven MOA by reading our CMO Nick West’s latest article in @CardiacInterv:  US Rx only. Safety Info: availability may vary by country.

Joining CITIC2026? Don’t miss our #ShockwaveIVL# symposium! Led by Prof. Flavio Ribichini (@FlavioRibichini), Dr. Carla Agatiello (@CarlaAgatiello), and Dr. Félix Damas (@felixdamasds), this session will explore the role of Shockwave IVL in addressing complex coronary calcium. Discover key insights from EMPOWER CAD and gain a deeper understanding of how Shockwave IVL performs in challenging lesions. Save the date and join the discussion as we advance the standard of care in coronary intervention. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

Muchas gracias CITIC2026! Once again, @CiticMexico proved to be a leading international forum in cardiovascular interventions and an ideal platform for #ShockwaveIVL# to share its MOA and showcase its technology. Thank you to all physicians and attendees who joined our sessions and contributed to valuable discussions on the management of complex coronary calcium. @aadilshaukat34 @McInerneyAngela Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

Thank you to Dr Misty Humphries (@mhumphriesmd), Dr Meryl Logan (@ProleneQueen) and Dr Chris Paprzycki (@CincyVascSurg) for presenting so many educational #ShockwaveIVL# cases at #VAM26#! When it comes to treating deep calcium, shockwave really excels at that.” – Dr. Misty Humphries We enjoyed the discussion around your real-world #ShockwaveE8# and #ShockwaveJavelin# cases, and are sure this session sparked calcium-cracking insights for all who attended. @VascularSVS #VascularLive# #VascSurg# Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

For Healthcare Professionals Only: Dziękuję, Poland! What inspiring days of clinical exchange. Last week, our latest device made its debut at the 2nd Kashubian-Pomeranian Interventional Cardiology Workshop, bringing together a highly engaged community of interventional cardiologists. The first clinical use, led by Dr. Michał Hawranek (@HawranekMichal), lays the groundwork for the rapid adoption of next‑generation #ShockwaveIVL# technologies in Poland and further progress in calcium modification. It was a pleasure to connect and exchange valuable perspectives on how this innovation can support daily practice and advance calcium modification. Together, we’re shaping what’s next in calcium treatment. For professional use only. US Rx only. Safety Info: Product availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.